# MASTER DOSSIER — John P. Frawley, toxicologist (Hercules Inc.)

*Documentary reconstruction of his career, his "de minimis" / toxicological-insignificance
proposal and the FDA's reaction, and his role in the Agent Orange / dioxin litigation.*

**Evidence grading on every claim:** **[CONFIRMED-primary]** (a primary source was read) ·
**[secondary]** (a secondary source asserts it) · **[absence-of-evidence]** (searched, not found).
Companion files: `02_Frawley_bibliography.md` · `03_DOCUMENT_REGISTER.md` · `04_TIMELINE.md` ·
`05_OPEN_QUESTIONS.md` · `06_ANALYTIC_MEMO.md`. Verbatim quotes are kept under 25 words.

> **Production note.** Built from two local primary PDFs (Frawley 1965, 1967) plus a 19-agent
> research workflow (8 reconnaissance + 4 document-acquisition + adversarial verification). The
> Justia full-text 403s the automated fetcher throughout; the opinion text was recovered via the
> `cetient.com` and `r.jina.ai` reader-proxy mirrors and cross-checked across three independent agents.

---

## 0. Headline findings

1. **The de minimis proposal is fully reconstructed**, including the part the brief most wanted —
   *what the FDA actually did with it*: "serious consideration" → referral to an **NAS/NRC Food
   Protection Committee** (the 1969 monograph *Guidelines for Estimating Toxicologically
   Insignificant Levels of Chemicals in Food*) → the FDA **National Conference on Indirect Additives**
   (Feb 1968) → the **Ramsey Proposal** (50 ppb), **abandoned 3 June 1971** as legally unworkable.
   The idea was resurrected by **Rulis (FDA, 1987)**, who **explicitly credits Frawley**, and codified
   in the **1995 Threshold of Regulation rule** (21 CFR 170.39) — which cites Rulis, *not* Frawley.
2. **The congressional question is resolved: there is no evidence Frawley ever testified before
   Congress.** The Aug 1967 Dingell hearing witness was FDA Commissioner **Goddard**, not Frawley;
   Frawley is **absent from the (directly read) witness index of the 1970 Senate 2,4,5-T hearings.**
3. **Frawley is at the evidentiary center of the Agent Orange MDL.** His deposition + affidavit are
   the sole basis on which **Hercules won summary judgment** on the government-contractor defense
   (565 F. Supp. 1263) — *a victory later **withdrawn** by Chief Judge Weinstein before the 1984 settlement.*
4. **A crown-jewel primary document ties Frawley directly to the inter-company dioxin discussions:**
   the **19 March 1965 V.K. Rowe (Dow) → "Dr. John P. Frawley, Hercules Powder Company"** letter
   (Poison Papers Bates **B 1575**; DocumentCloud **3253794**), read in full.
5. **Document A and Document B — BOTH now have concrete primary handles (upgraded 2026-06-09).** **Doc A**
   (3 Jul 1963 Frawley→Rowe letter) is indexed as exhibit **H281 14-1 5** in a local MDL-381 deposition/exhibit
   packet (ToxicDocs `RBqNnvVr…`) — the first production locator ever found (scan still to pull). **Doc B** is
   now confirmed as a **12 Jul 1965 confidential Frawley/Hercules memo recording a 9 Jul 1965 phone call with
   Earl Farnham of Dow** — its verbatim wording ("Dow was extremely frightened that this situation might
   explode"… "the whole industry will suffer"… "fearful of a congressional investigation") recovered from a
   **litigation brief** (ToxicDocs `jyBDvYGz…`) and indexed in Poison Papers DowDATA as Bates **A303**, NOT just
   the old secondary paraphrase. The old "rabbit-liver study" detail is **absent** → it was a conflation.
   **The consistency analysis is in `06_ANALYTIC_MEMO.md`; full acquisition sweep in
   `_workflow_results/ACQUISITION_TARGETS_2026-06-09.md`.**
6. **ToxicDocs — corrected, downloaded, and MINED (see `07_TOXICDOCS_FINDINGS`).** An earlier conclusion
   that ToxicDocs held nothing was **wrong** (it relied on Google's incomplete index). The native search has
   **251 "Frawley" documents**; all 251 are now **downloaded locally** (`./toxicdocs/`) with text and
   triaged (**59 confirmed / 88 likely**). Identity is **confirmed** (e.g. *"Jack Frawley, Chief
   Toxicologist, Hercules Inc"*). The payoff is large: the **Allied Signal/SPI vinyl-chloride cluster
   (1966–72) is the chemical-industry coalition's internal correspondence promoting and negotiating
   Frawley's de minimis proposal with the FDA** — upgrading Strand I from "a published proposal FDA mulled"
   to **"the banner of an organized multi-association industry campaign."** Frawley also recurs across the
   PCB/lead/asbestos/dioxin product-defense collections. (Full-text mining also caught a real **namesake** —
   a 1949 beryllium/occupational-lung "John P. Frawley, Ph.D." — and corrected a false PCB-paper attribution.)

---

## 1. Subject identity & disambiguation

**Verified identity:** **John P. Frawley, PhD** — U.S. FDA Division of Pharmacology toxicologist
(publishing 1950–59 with O. Garth Fitzhugh and Arthur A. Nelson); chief toxicologist / General
Manager of Health, Environment and Safety at **Hercules Inc.**, Wilmington DE; **SOT charter member
(1961)** and founding Councilor (1961–62); later **ISRTP president (1989–90)**; principal of the
consultancy **Health & Environment International Ltd.** Same-name non-targets (priest d.2013; Patrick
J. Frawley Jr. d.1998; linguist William Frawley) were excluded throughout.

| Item | Finding | Grade |
|---|---|---|
| PhD; SOT charter member 1961 | "John P. Frawley, PhD" on the official SOT charter-members list; founding Councilor (1-yr term) with Lehman & Oser | **[CONFIRMED-primary]** (toxicology.org) |
| FDA Division of Pharmacology start | Co-authored Fitzhugh–Nelson–Frawley from 1950; wrote the 1968 tribute to mentor O. Garth Fitzhugh | **[CONFIRMED-primary]** (PMID 14774791; 4876430) |
| "with Hercules since 1956" | Recited in the Agent Orange opinion from his own deposition | **[CONFIRMED-primary]** (565 F. Supp. at 1273) |
| **1987 award = Arnold J. Lehman Award** (NOT the "Merit Award") | SOT History: the Lehman Award went to Frawley; the 1987 **Merit Award** went to **Bo Holmstedt**. *Corrects the brief.* | **[CONFIRMED-primary]** (SOT History; Awards booklets) |
| Inaugural RTP article identified | **"The 1980s — A decade of change," *RTP* 1(1):3–7 (June 1981)** | **[CONFIRMED-primary]** (PMID 7186152) |
| ISRTP president 1989–90; W. Gary Flamm VP; Health & Environment Int'l Ltd. | Per SourceWatch (ISRTP records); primary roster not directly viewed | **[secondary]** |
| **Death ≈ 2003–2004** | No deceased asterisk in SOT 2002-03 booklet; asterisked in 2004-05 & 2013-14; absent from 2003-04 In Memoriam. Exact date / obituary **not found**. | **[CONFIRMED-primary]** for the bracket; **[absence-of-evidence]** for exact date |
| **PhD field = "Biological Chemistry"** (NEW, 2026-06-09) | Stated in the **Kemner v. Monsanto** witness list: "John P. Frawley… Ph.D. Biological Chemistry" (ToxicDocs `XRqYoX0mvYxZNM88K8VJ8qr3w`). *Institution & year still unknown.* | **[CONFIRMED-primary]** (field); **[absence-of-evidence]** (institution/year) |
| Birth date/place; PhD institution & year; exact Hercules title progression | Not located online (military-officer status in 1953 implies birth ~mid/late 1920s — inference only) | **[absence-of-evidence]** |
| **Second, likely-UNSEALED sworn testimony: *Kemner v. Monsanto*** (St. Clair Co., IL) — **deposed 8 Mar 1983 & 7–8 Feb 1984; testified at the Vertac trial** | Per the Kemner witness list (ToxicDocs `XRqYoX0…`). A route around the PTO-43 seal on the MDL 381 deposition. | **[P-cite]** (transcript not yet pulled) |

### ⚠ Open disambiguation: the 1953 Korean War / 46th MASH "1st Lt. J. P. Frawley"
Two workflow agents **disagreed**, and the question is genuinely unresolved:
- The **biography agent** identified the toxicologist with the "**John P. Frawley, 1st Lt., Medical
  Service Corps**" listed on the **46th MASH** Surgical Research Team (Korea, July 1953, with Curtis
  Artz and John Howard) — and with the eight **1955 combat-casualty papers**.
- The **bibliography agent** treated that MASH officer and the 1955 surgical papers as a **different**
  John P. Frawley and **excluded** them.
- **Neither proved its case.** The strongest *circumstantial* point for "same man": the toxicologist's
  publication record has a **gap from 1953 to 1955** that coincides exactly with the MASH service
  window, and a Medical Service Corps commission is the route by which an FDA pharmacologist would do
  shock/resuscitation physiology at a surgical-research team. **Treated as OPEN** — see `05_OPEN_QUESTIONS`
  (NARA military service record / Who's Who is the way to close it). *Do not assert either way.*

---

## 2. STRAND I — The de minimis / "toxicological insignificance" proposal and the FDA's reaction

### 2.1 Chronology and text history of the proposal
- **The commercial root (1964–65).** After the 1958 Food Additives Amendment, FDA refused to treat
  Hercules's food-grade rosins as safe without 2-year studies. Frawley's 1965 rosin paper states the
  problem plainly — >70 rosin products, **34** needing study at ~**$50,000 each** — and that the
  studies were "**conducted under contract by the Industrial Bio-Test Laboratories, of Northbrook,
  Ill.**" **[CONFIRMED-primary]** (Frawley 1965, pp. 65–68, local PDF). *This is the direct financial
  driver of the deregulatory proposal.*
- **First public airing — 14 Sept 1966.** At the **152nd ACS National Meeting, New York**, Frawley
  advanced the rule that any indirect additive used at **≤0.2% in the container** (contributing
  **<0.1 ppm to the diet**) is "toxicologically insignificant," *unless* it is a carcinogen, a
  pesticide/heavy metal, or toxic at **≤40 ppm**. A companion FDA-critical paper was given by
  packaging attorney **Jerome H. Heckman**. Data base then = 143 chronic studies. **[secondary]**
  (Keller & Heckman / PackagingLaw.com), corroborated by Frawley's own "last September… 143 studies"
  line **[CONFIRMED-primary]**.
- **Mature version — 25 Jan 1967, BIBRA London.** Published as *Food Cosmet. Toxicol.* 5(3):293–308
  (220 chronic studies). The diet threshold (0.1 ppm) and container threshold (0.2%) are stated on
  p. 296; the framing of the U.S. submission as **GRAS at 0.2%** "last September" and FDA's posture
  ("authorized me to tell you that they are giving it serious consideration") on p. 301. **[CONFIRMED-primary]** (local PDF).
- **Third public airing — 13 Feb 1968, the FDA National Conference itself (the de minimis address *to FDA*).**
  Frawley's conference paper "**A Reasoned Approach to Regulation Based on Toxicologic Considerations**" was
  printed in *Food Drug Cosm. Law J.* **23(5):260–270 (May 1968)** — **now read in full, local PDF.** The
  data base has grown to **245 chronic studies** ("$15–20M… over 90% of all such studies"); the rule is
  pinned to **Regulation 121.2500(d)** ("≤0.2% by weight of the container… not heavy metals… or
  pesticides"); and he claims **"twenty-four other toxicologists… supported this proposal in writing to the
  FDA."** He also states the **financial driver in the first person**: "I personally had spent over a million
  dollars of my Corporation's money investigating the safety of food packaging materials… it was all wasted."
  *This is the Frawley side of the Summerson "sheer nonsense" showdown — both sides now in primary text*
  (`08_VINYL_CHLORIDE_CAMPAIGN.md` §4; excerpt in `sources/`). **[CONFIRMED-primary]** (local PDF).
  Data-base progression across the three airings: **143** (ACS 1966) → **220** (BIBRA 1967) → **245** (FDA 1968).

### 2.2 What the FDA actually did — the answer to the central Strand I question
- **"Serious consideration" was real but produced no rule.** **[CONFIRMED-primary]** (Frawley 1967, p. 301).
- **Referral to the National Academy of Sciences.** The NAS/NRC **Food Protection Committee (Food and
  Nutrition Board)** reviewed the ACS paper and issued **"Guidelines for Estimating Toxicologically
  Insignificant Levels of Chemicals in Food"** (1969, 11 pp.), reprinted as the Appendix to *Evaluating the
  Safety of Food Chemicals* (NAS-NRC **1970**, 62 pp.; NAP record 20498). **NOW READ IN FULL (local PDF,
  2026-06-09) — [CONFIRMED-primary]:** the report builds on the **1/100 "no-adverse-effect level"** factor (the
  same Lehman–Fitzhugh 100-fold margin) and recommends **0.1 ppm = "toxicologically insignificant"** for
  established commercial chemicals (≥5 yr, not heavy-metal, not biologically active) — **Frawley's exact
  threshold** — with a **1.0 ppm** presumption for substances cleared by four structural-analogy criteria, plus
  carcinogen/pesticide/heavy-metal exclusions. *(Corrects the prior "operative presumption 1.0 ppm" reading:
  0.1 ppm is the headline figure for commercial chemicals; 1.0 ppm is the looser analogy tier.)* Its closing
  rationale ("eliminate wasteful diversion of scientific resources") echoes Frawley, and it **cites Frawley 1967**
  (ref 4). **The drafting Task Force named in the printed Preface — H.F. Smyth Jr. (chair), J.M. Coon,
  J.P. Frawley, R.L. Hall, B.L. Oser, A.T. Schramm, J.A. Zapp** (Committee chair W.J. Darby) — **included Frawley
  himself.** *(Nuance: his 12 July 1968 letter, UCSF Darby **yhgd0228**, declined an active drafting part, yet the
  Preface still lists him.)* So the idea "beaten" at the Feb 1968 FDA conference was, within a year, **recommended
  by the National Academy of Sciences**, number and all.
- **FDA National Conference on Indirect Food Additives, 13 Feb 1968**, opened by Commissioner Goddard —
  convened partly to answer Rep. Dingell's unanswered August-1967 questions. **Now [CONFIRMED-primary]:**
  Frawley's own conference address survives as *Food Drug Cosm. Law J.* 23(5):260–270 (local PDF), which
  dates and locates the conference and restates his proposal *to FDA*; FDA Bureau of Science chief
  **W. H. Summerson's** rebuttal at the same session is independently in primary text (`08_VINYL_CHLORIDE` §4).
  *(Frawley's paper was listed on the SPI agenda as "Toxicology of Indirect Food Additives.")*
- **The Ramsey Proposal (1969–71).** FDA's Dr. Lessel L. Ramsey drafted an exemption for substances
  migrating **≤50 ppb**; at a **3 June 1971** meeting FDA concluded it could not proceed, deeming it
  "scientifically sound" but legally unworkable. *This is the concrete fate of Frawley's idea inside
  FDA.* **[secondary]** (Heckman). **→ Now documented from primary industry files** in
  `08_VINYL_CHLORIDE_CAMPAIGN.md`: the FDA 0.05-ppm "Ramsey" counter-proposal, the named FDA actors, and
  the Feb 1968 National Conference where FDA's Bureau of Science chief **W. H. Summerson** publicly called
  the proposal's core device **"sheer nonsense"** while conceding its "soundness."

### 2.3 Propagation into modern regulation (the citation lineage)
- **Rulis (FDA, 1987)** "De Minimis and the Threshold of Regulation" **explicitly credits Frawley**:
  the toxicity pattern was "duly noted by Frawley in 1967, using a different data base" (ref. 2 =
  Frawley 1967). **[CONFIRMED-primary]** (full text downloaded; regulations.gov mirror).
- Lineage **Frawley (1967) → Flamm & Rulis (1987–92) → Munro (1990, 1996) → Kroes/EFSA (2000–04) → TTC**
  is confirmed with exact citations. **[secondary]** (FPF TTC dossier 2024).
- The **1995 FDA Threshold of Regulation final rule** (21 CFR 170.39; **60 FR 36582**, 17 Jul 1995;
  0.5 ppb) is the codification — but its preamble **cites Rulis (1992), not Frawley** (govinfo full-text:
  no "Frawley" hit). **[CONFIRMED-primary]**. Critics of the principle exist (e.g., "Against the De
  Minimis Principle," PMC7317961). **[secondary]**.
- **The parallel LEGAL track (added 2026-06-10 — full file `10_DE_MINIMIS_LEGAL_LINEAGE.md`).** The citation
  lineage above is only half the story: de minimis became *enforceable* through the **courts**, not the
  citation chain. **Monsanto Co. v. Kennedy, 613 F.2d 947 (D.C. Cir. 1979)** (Leventhal, J.) gave FDA the
  de minimis authority it had declared it **lacked** when it killed the Ramsey proposal in 1971 — and its
  **co-petitioner was the Society of the Plastics Industry, the same body that ran Frawley's 1967–68
  campaign** (`07`/`08`). **Public Citizen v. Young (1987)** and **Les v. Reilly (1992)** then capped the
  doctrine at the **Delaney carcinogen line** — Frawley's own carve-out. The **1995 rule's preamble rests
  expressly on *Monsanto*, recites *de minimis non curat lex*, and conditions the exemption on
  non-carcinogenicity per *Public Citizen*.** So the rule that codified Frawley's *kind* of number was built
  on the legal authority his trade-association allies helped win. **[CONFIRMED-primary]** (local 60 FR text;
  case holdings read/rendered).

### 2.4 Conflict of interest
The COI is visible in the documents but was apparently never disclosed as such at the time. Frawley's
employer sold the rosin/CMC/packaging chemistry his proposal would deregulate; the supporting data came
from **Hercules** (1967 ref. 3) and **IBT** (1967 ref. 26) — IBT being the lab later destroyed by the
1977–83 data-fraud scandal. **No contemporaneous formal COI disclosure beyond his Hercules by-line was
located.** **[CONFIRMED-primary]** that the interest existed; **[absence-of-evidence]** that it was flagged.

---

## 3. STRAND II — Congressional / governmental / adversarial appearances

### 3.1 Did Frawley ever testify before Congress? — **No evidence that he did.**
- **Aug 1967 Dingell hearing (House Select Small Business, Subcommittee on Activities of Regulatory
  Agencies).** The FDA witness was **Commissioner James L. Goddard, not Frawley** — Goddard asked to
  answer the indirect-additive questions in writing within 30 days and (per Heckman) never did, which
  is why FDA convened the Feb 1968 conference. **[secondary]** (Heckman first-hand) + **[CONFIRMED-primary]**
  that the House subcommittee heard a "public witness" on drug-industry matters and that Goddard
  testified to the *Senate* Monopoly subcommittee that day (Cong. Rec. Daily Digest D406, 10 Aug 1967).
  *The brief's "LIKELY FALSE" flag on Frawley-testified-at-Dingell is confirmed correct.*
- **1970 Senate "Effects of 2,4,5-T on Man and the Environment" (Hart subcommittee, 7 & 15 Apr 1970).**
  The **printed witness index was read directly: Frawley is absent** (grep = 0 hits); the industry
  witness was **Dow** (Johnson, Blair, Rowe, Lynn); the only Hercules mention is incidental (30 gal of
  2,4,5-T for Arizona spraying). **[CONFIRMED-primary]** (NAL full-text PDF).
- **Cyclamate (1969–70), saccharin (1977), pesticide, Agent Orange/veterans hearings:** no Frawley
  witness or statement located. **[absence-of-evidence]** — most pre-1995 printed witness indexes are
  not digitized full-view; a definitive negative needs ProQuest Congressional / CIS name-index sweeps.

> **Resolved by adversarial verification — and it produced a major new fact.** The loose thread (a UCSF
> tobacco-collection "Frawley" congressional item) was run down: in **March–April 1994** a **"Statement of
> John P. Frawley, Ph.D. Before the [House] Subcommittee on Health and the Environment"** was **drafted
> for the Waxman tobacco hearings** ("Regulation of Tobacco Products," 103rd Cong.). UCSF metadata
> confirms it is *our* Frawley (*"FRAWLEY JP # HEALTH & ENVIRONMENT INTERNATIONAL LTD,"* Hercules, SOT,
> ex-FDA), held in the **Tobacco Institute** / **RJR** legal files, **marked DRAFT with Covington &
> Burling privilege-log boilerplate.** But the **complete printed record of all seven 1994 hearing dates
> contains zero "Frawley"** — the statement was **never delivered or entered into the record.** So the
> "never testified before Congress" finding **stands**, *and* we learn that Frawley spent his last active
> years as a **tobacco-industry consultant** (UCSF IDL zqxb0104, lhyg0018, hmkb0121, tjhg0001, xhyn0050).
> **[CONFIRMED-primary]** (UCSF metadata + full 1994 hearing record). See `06_ANALYTIC_MEMO` Part 4.

### 3.2 Adversarial settings he *did* appear in (courts/depositions)
- **In re "Agent Orange" Prod. Liab. Litig., MDL 381** — **deposed** and filed an **answering
  affidavit** for Hercules; both are quoted in **565 F. Supp. 1263** (see Strand III). **[CONFIRMED-primary]**.
- **United States v. Vertac Chemical Corp., 671 F. Supp. 595 (E.D. Ark. 1987)** — a "**Frawley
  deposition p. 45**" is cited as **PX 213** for Hercules' ~$60,000/month leachate costs (surname only;
  almost certainly J.P. Frawley). **[CONFIRMED-primary]** (CourtListener via proxy).
- **Not** named in *O'Dell v. Hercules*, 904 F.2d 1194 (the Jacksonville dioxin trial), nor in the
  later Vertac opinions (966 F. Supp. 1491; 79/33 F. Supp. 2d). **[absence-of-evidence]** (he could
  still appear in the sealed trial record).
- **EPA FIFRA 2,4,5-T/Silvex proceedings (Docket 295/415):** **no record of Frawley as a Hercules
  witness/affiant**; Dow (V.K. Rowe) was the industry witness. **[absence-of-evidence]** — consistent
  with the brief's expectation.

---

## 4. STRAND III — Hercules, Dow, Monsanto and the dioxin/herbicide nexus

### 4.1 Hercules's 2,4,5-T / Agent Orange manufacturing
- Hercules **bought the Jacksonville, Arkansas plant in 1961** (later Vertac) and produced **Agent
  Orange (50/50 n-butyl esters of 2,4-D and 2,4,5-T)** for DoD under contracts **8 May 1964 – 20 May
  1968**. **[CONFIRMED-primary]** for the contract dates (565 F. Supp. at 1273); **[secondary]** for
  the 1961 purchase (Encyclopedia of Arkansas / EPA).
- **Dioxin profile of Hercules product:** per the court record, "very low" at March 1965, then "**no
  measurable dioxin**" from Jan 1966–May 1970 **except one Sept 1966 test at .1 ppm** — at the very low
  end of the Vietnam-era 2,4,5-T distribution (others up to ~30–50 ppm TCDD). **[CONFIRMED-primary]**
  (565 F. Supp. at 1273–74) + **[secondary]** (NTP/NAP ranges).
- **Long tail:** the Jacksonville site (≈29,000 abandoned drums; 1979 dioxin-in-fish) became a major
  Superfund site; Hercules paid **~$102.9M (1998)** and **$124M (2007)** in Vertac judgments.
  **[secondary]** (DOJ/Encyclopedia of Arkansas).

### 4.2 Inter-company dynamics in the record (1949–1965)
- **Monsanto's 1949 Nitro, WV explosion/chloracne** — the court found "Dow must have known" of it;
  Frawley swore Hercules did not learn of it until Feb 1965. **[CONFIRMED-primary]** (565 F. Supp. at 1269).
- **Feb 1965** — Frawley's sworn first knowledge of 2,4,5-T industrial health problems, from Dow.
  **[CONFIRMED-primary]** (at 1273).
- **19 Mar 1965 — the crown-jewel document.** **V.K. Rowe (Dow) wrote to manufacturers of
  2,4,5-trichlorophenol, including by name "Dr. John P. Frawley, Hercules Powder Company"** (and
  Monsanto's Emmet Kelly, Hooker, Diamond Alkali), convening a meeting on "highly toxic impurities" in
  2,4,5-trichlorophenol. Read in full. **[CONFIRMED-primary]** — **Poison Papers Bates B 1575 /
  DocumentCloud 3253794.**
- **24 Mar 1965 — the "Chloracne Problem Meeting" at Dow Midland** (Dow, Diamond Alkali, Hercules,
  Hooker). Frawley attended and received Dow's analyses showing Hercules's product had "a very low
  level of dioxin." **[CONFIRMED-primary]** (at 1273). A Hercules memo of the meeting (Poison Papers)
  records Dow "fearful of a congressional investigation"; Hercules's view that the PHS "would be very
  happy to get in the act." **[secondary]**.
- **24 Jun 1965 — Dow's V.K. Rowe to Ross Milholland:** dioxin "exceptionally toxic… chloracne and
  systemic injury," the whole 2,4,5-T industry would be "hard hit" by restrictive legislation, with a
  "do not reproduce outside Dow" postscript. **[secondary]** (multiple quoters; primary scan not isolated).

### 4.3 The litigation outcome (and a correction to the brief)
- **565 F. Supp. 1263 (Pratt, J.; order 20 May 1983):** Hercules **won summary judgment** on the
  government-contractor defense, resting entirely on Frawley's testimony — the court reasoning that
  because Hercules's product "was free of the contamination… its knowledge could not have exceeded that
  of the government." **[CONFIRMED-primary]**.
- **Correction:** Chief Judge **Weinstein later WITHDREW Pratt's opinion** and reinstated the
  defendants, holding the government-contractor defense could not be resolved before trial; the case
  then **settled in May 1984** ($180M fund; Hercules' share **$18,772,568**). **[CONFIRMED-primary]** —
  the SJ opinion was **withdrawn before judgment was entered** (procedural recitation in *Hercules v.
  United States*, 516 U.S. 417, held at `sources/516_US_417_Hercules-v-US_1996_CornellLII.html`; citing
  *In re "Agent Orange"*, 597 F. Supp. 740, 753 (E.D.N.Y. 1984)). *Frawley's sworn account never ripened
  into a judgment.*
- **Hercules, Inc. v. United States, 516 U.S. 417 (1996):** Hercules could not recover its
  settlement/defense costs from the U.S. under the Tucker Act. **[CONFIRMED-primary]**.

### 4.4 The two key letters (full analysis in `06_ANALYTIC_MEMO.md`)
- **Document A — 3 July 1963 Frawley → Rowe.** Real (paraphrased at 565 F. Supp. 1273: re USDA Dr.
  John Leary's request to test phenoxy herbicides; per Frawley's affidavit the hazards "relate to
  2,4-D, not to 2,4,5-T"). **PRODUCTION LOCATOR NOW FOUND (2026-06-09):** indexed as exhibit **H281 14-1 5**,
  "john p. frawley's letter to V. K. rowe of 07-03-63," in a local MDL-381 deposition/exhibit packet
  (ToxicDocs `RBqNnvVrnkZ54xyyyqd9OyKV`, lines 57656–57680). The **scan itself** is still to be pulled, but this
  is the first concrete handle. **[CONFIRMED-primary]** (existence/characterization + exhibit locator);
  **[absence-of-evidence]** (the page image).
- **Document B — 12 July 1965 Frawley internal Hercules memo. UPGRADED (2026-06-09) from [secondary] to
  [CONFIRMED-primary] for the wording.** It records a **9 July 1965 telephone call with Earl Farnham of Dow**:
  "Dow was extremely frightened that this situation might explode"; competitors marketing 2,4,5-T with "alarming
  amounts of acnegen"; "the whole industry will suffer"; Dow "particularly fearful of a congressional
  investigation." This verbatim text + exact date/author/subject is now recovered from an **Agent Orange MDL
  litigation brief** (ToxicDocs `jyBDvYGzG58gkKk3VmDbjxLK5`, l.14017–14038) and indexed in Poison Papers DowDATA
  as Bates **A303 / 650712** — *not* the uncited U.S. Veteran Dispatch narrative we previously relied on. **The
  Bates-stamped memo scan is the remaining target.**
  > Correction: the **"rabbit-liver study"** detail in the old secondary account appears **nowhere** in the
  > actual memo text → it was a **conflation**. The memo is a Frawley account of a Dow (Farnham) phone call,
  > not a lab study. (The words also appear nowhere in 565 F. Supp. 1263 — the court opinion was never its source.)

---
*Continued in `06_ANALYTIC_MEMO.md` (consistency of the 1983 sworn account vs the 1960s documents;
the industrial-role / regulatory-advocacy relationship) and `05_OPEN_QUESTIONS.md` (next actions,
NARA + FOIA drafts, running search log).*